4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Gamma Hydroxybutyric Acid.
Abiraterone
The serum concentration of Hydromorphone can be increased when it is combined with Abiraterone.
Acepromazine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Acepromazine.
Advertisement
Aceprometazine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Aceprometazine.
Acetazolamide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Acetazolamide.
Aclidinium
The risk or severity of adverse effects can be increased when Aclidinium is combined with Hydromorphone.
Advertisement
Alfaxalone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Alfaxalone.
Alfentanil
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Alfentanil.
Alphaprodine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Alphaprodine.
Advertisement
Alprazolam
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Alprazolam.
Alvimopan
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Alvimopan.
Alvimopan Anhydrous
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Alvimopan.
Amiloride
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Amiloride.
Amiodarone
The metabolism of Hydromorphone can be decreased when combined with Amiodarone.
Amisulpride
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Amisulpride.
Amitriptyline
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Amitriptyline.
Ammonium Chloride
Ammonium chloride may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.
Amobarbital
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Amobarbital.
Amoxapine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Amoxapine.
Amphetamine
The risk or severity of adverse effects can be increased when Amphetamine is combined with Hydromorphone.
Apalutamide
The serum concentration of Hydromorphone can be decreased when it is combined with Apalutamide.
Aprepitant
The serum concentration of Hydromorphone can be increased when it is combined with Aprepitant.
Aripiprazole
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Aripiprazole.
Artemether
The metabolism of Hydromorphone can be decreased when combined with Artemether.
Articaine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Articaine.
Asenapine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Asenapine.
Atazanavir
The metabolism of Hydromorphone can be decreased when combined with Atazanavir.
Atomoxetine
The metabolism of Hydromorphone can be decreased when combined with Atomoxetine.
Atracurium
The risk or severity of adverse effects can be increased when Atracurium is combined with Hydromorphone.
Atracurium Besylate
The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Hydromorphone.
Atropine
The risk or severity of adverse effects can be increased when Atropine is combined with Hydromorphone.
Azelastine
Hydromorphone may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Azosemide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Azosemide.
Baclofen
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Baclofen.
Barbital
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Barbital.
Benactyzine
The risk or severity of adverse effects can be increased when Benactyzine is combined with Hydromorphone.
Bendroflumethiazide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Bendroflumethiazide.
Benoxinate
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Oxybuprocaine.
Benperidol
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Benperidol.
Benzocaine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Benzocaine.
Benzphetamine
Benzphetamine may increase the analgesic activities of Hydromorphone.
Benztropine
The risk or severity of adverse effects can be increased when Benzatropine is combined with Hydromorphone.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Benzyl alcohol.
Betaxolol
The metabolism of Hydromorphone can be decreased when combined with Betaxolol.
Biperiden
The risk or severity of adverse effects can be increased when Biperiden is combined with Hydromorphone.
Boceprevir
The metabolism of Hydromorphone can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Hydromorphone can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Hydromorphone can be decreased when it is combined with Bosentan.
Brexpiprazole
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Brexpiprazole.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Hydromorphone.
Bromazepam
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Bromazepam.
Bromperidol
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Bromperidol.
Brompheniramine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Brompheniramine.
Brotizolam
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Brotizolam.
Bumetanide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Bumetanide.
Bupivacaine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Bupivacaine.
Buprenorphine
Hydromorphone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Bupropion
The metabolism of Hydromorphone can be decreased when combined with Bupropion.
Buspirone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Buspirone.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Hydromorphone.
Butalbital
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Butalbital.
Butamben
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Butamben.
Butobarbital
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Butethal.
Butorphanol
Butorphanol may decrease the analgesic activities of Hydromorphone.
Butylscopolamine
The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Hydromorphone.
Canrenoate
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Canrenoic acid.
Canrenoic Acid
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Canrenoic acid.
Canrenone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Canrenone.
Capecitabine
The metabolism of Hydromorphone can be decreased when combined with Capecitabine.
Carbamazepine
The metabolism of Hydromorphone can be increased when combined with Carbamazepine.
Carbinoxamine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Carbinoxamine.
Carisoprodol
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Carisoprodol.
Celecoxib
The metabolism of Hydromorphone can be decreased when combined with Celecoxib.
Ceritinib
The serum concentration of Hydromorphone can be increased when it is combined with Ceritinib.
Cetirizine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Cetirizine.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Chloral hydrate.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Chlordiazepoxide.
Chlormethiazole
The risk or severity of adverse effects can be increased when Hydromorphone is combined with clomethiazole.
Chlormezanone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Chlormezanone.
Chloroprocaine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Chloroprocaine.
Chloroquine
The metabolism of Hydromorphone can be decreased when combined with Chloroquine.
Chlorothiazide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Chlorothiazide.
Chlorpheniramine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Chlorphenamine.
CHLORPHENIRAMINE POLISTIREX
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Chlorphenamine.
Chlorphenoxamine
The risk or severity of adverse effects can be increased when Chlorphenoxamine is combined with Hydromorphone.
Chlorpromazine
The metabolism of Hydromorphone can be decreased when combined with Chlorpromazine.
Chlorprothixene
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Chlorprothixene.
Chlorthalidone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Chlorthalidone.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Chlorzoxazone.
Cholecalciferol
The metabolism of Hydromorphone can be decreased when combined with Cholecalciferol.
Cicletanine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Cicletanine.
Cimetidine
The metabolism of Hydromorphone can be decreased when combined with Cimetidine.
Cinacalcet
The metabolism of Hydromorphone can be decreased when combined with Cinacalcet.
Citalopram
The metabolism of Hydromorphone can be decreased when combined with Citalopram.
Clarithromycin
The metabolism of Hydromorphone can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Hydromorphone can be decreased when combined with Clemastine.
Clidinium
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Clidinium.
Clidinium bromide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Clidinium.
Clobazam
The metabolism of Hydromorphone can be decreased when combined with Clobazam.
Clomipramine
The metabolism of Hydromorphone can be decreased when combined with Clomipramine.
Clonazepam
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Clonazepam.
Clonidine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Clonidine.
Clopamide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Clopamide.
Clorazepate
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Clorazepate.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Clorazepate.
Clotrimazole
The metabolism of Hydromorphone can be decreased when combined with Clotrimazole.
Clozapine
The metabolism of Hydromorphone can be decreased when combined with Clozapine.
Cobicistat
The serum concentration of Hydromorphone can be increased when it is combined with Cobicistat.
Cocaine
The metabolism of Hydromorphone can be decreased when combined with Cocaine.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Hydromorphone.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Hydromorphone.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Hydromorphone.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Hydromorphone.
Crisaborole
The metabolism of Hydromorphone can be decreased when combined with Crisaborole.
Crizotinib
The metabolism of Hydromorphone can be decreased when combined with Crizotinib.
Cyclizine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Cyclizine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Cyclobenzaprine.
Cyclopenthiazide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Cyclopenthiazide.
Cyclopentolate
The risk or severity of adverse effects can be increased when Cyclopentolate is combined with Hydromorphone.
Cyclosporine
The metabolism of Hydromorphone can be decreased when combined with Cyclosporine.
Cyclothiazide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Cyclothiazide.
Cyproheptadine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Cyproheptadine.
Dabrafenib
The serum concentration of Hydromorphone can be decreased when it is combined with Dabrafenib.
Dantrolene
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Dantrolene.
Dapiprazole
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Dapiprazole.
Darifenacin
The metabolism of Hydromorphone can be decreased when combined with Darifenacin.
Darunavir
The serum concentration of Hydromorphone can be increased when it is combined with Darunavir.
Dasatinib
The serum concentration of Hydromorphone can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Hydromorphone can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Hydromorphone can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Hydromorphone can be decreased when combined with Delavirdine.
Desflurane
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Desflurane.
Desipramine
The metabolism of Hydromorphone can be decreased when combined with Desipramine.
Desloratadine
The risk or severity of adverse effects can be increased when Desloratadine is combined with Hydromorphone.
Desmopressin
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Desmopressin.
Desvenlafaxine
Hydromorphone may increase the serotonergic activities of Desvenlafaxine.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Dexbrompheniramine.
Dexetimide
The risk or severity of adverse effects can be increased when Dexetimide is combined with Hydromorphone.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Dexmedetomidine.
Dextroamphetamine
Dextroamphetamine may increase the analgesic activities of Hydromorphone.
Dextromoramide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Dextromoramide.
Dezocine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Dezocine.
Diazepam
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Diazepam.
Dibucaine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Cinchocaine.
Dicyclomine
The risk or severity of adverse effects can be increased when Dicyclomine is combined with Hydromorphone.
Diethylpropion
Diethylpropion may increase the analgesic activities of Hydromorphone.
Difenoxin
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Difenoxin.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Dihydrocodeine.
Dihydroergotamine
The metabolism of Hydromorphone can be decreased when combined with Dihydroergotamine.
Diltiazem
The metabolism of Hydromorphone can be decreased when combined with Diltiazem.
Dimenhydrinate
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Dimenhydrinate.
Diphenhydramine
The metabolism of Hydromorphone can be decreased when combined with Diphenhydramine.
Diphenoxylate
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Diphenoxylate.
Dothiepin
The metabolism of Hydromorphone can be decreased when combined with Dosulepin.
Doxepin
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Doxepin.
Doxycycline
The metabolism of Hydromorphone can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Hydromorphone can be decreased when combined with Doxycycline.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Hydromorphone.
Dronedarone
The metabolism of Hydromorphone can be decreased when combined with Dronedarone.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Hydromorphone.
Drospirenone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Drospirenone.
Duloxetine
The metabolism of Hydromorphone can be decreased when combined with Duloxetine.
Dyclonine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Dyclonine.
Efavirenz
The metabolism of Hydromorphone can be decreased when combined with Efavirenz.
Eliglustat
The metabolism of Hydromorphone can be decreased when combined with Eliglustat.
Eluxadoline
Hydromorphone may increase the constipating activities of Eluxadoline.
Enflurane
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Enflurane.
Entacapone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Entacapone.
Enzalutamide
The serum concentration of Hydromorphone can be decreased when it is combined with Enzalutamide.
Eplerenone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Eplerenone.
Erythromycin
The metabolism of Hydromorphone can be decreased when combined with Erythromycin.
Escitalopram
Hydromorphone may increase the serotonergic activities of Escitalopram.
Estazolam
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Estazolam.
Eszopiclone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Eszopiclone.
Ethacrynate
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Etacrynic acid.
Ethacrynic Acid
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Etacrynic acid.
Ethanol
Hydromorphone may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Ethchlorvynol.
Ethosuximide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Ethosuximide.
Ethotoin
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Ethotoin.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Ethyl chloride.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Ethyl loflazepate.
Ethylmorphine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Ethylmorphine.
Etidocaine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Etidocaine.
Etifoxine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Etifoxine.
Etomidate
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Etomidate.
Etravirine
The metabolism of Hydromorphone can be decreased when combined with Etravirine.
Ezogabine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Ezogabine.
Felbamate
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Felbamate.
Fentanyl
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Fentanyl.
Fesoterodine
The risk or severity of adverse effects can be increased when Fesoterodine is combined with Hydromorphone.
Fexofenadine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Fexofenadine.
Flibanserin
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Flibanserin.
Floxuridine
The metabolism of Hydromorphone can be decreased when combined with Floxuridine.
Fluconazole
The metabolism of Hydromorphone can be decreased when combined with Fluconazole.
Flunarizine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Flunarizine.
Flunitrazepam
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Flunitrazepam.
Fluorouracil
The metabolism of Hydromorphone can be decreased when combined with Fluorouracil.
Fluoxetine
The metabolism of Hydromorphone can be decreased when combined with Fluoxetine.
Flupenthixol
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Flupentixol.
Fluphenazine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Fluphenazine.
Flurazepam
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Flurazepam.
Fluspirilene
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Fluspirilene.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Fluticasone propionate.
Fluvastatin
The metabolism of Hydromorphone can be decreased when combined with Fluvastatin.
Fluvoxamine
The metabolism of Hydromorphone can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Hydromorphone can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Hydromorphone can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The metabolism of Hydromorphone can be increased when combined with Fosphenytoin.
Fospropofol
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Fospropofol.
Furazolidone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Furazolidone.
Furosemide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Furosemide.
Fusidate
The serum concentration of Hydromorphone can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Hydromorphone can be increased when it is combined with Fusidic Acid.
Gabapentin
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Gabapentin.
Gabapentin Enacarbil
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Gabapentin Enacarbil.
Gallamine Triethiodide
The risk or severity of adverse effects can be increased when Gallamine Triethiodide is combined with Hydromorphone.
Gemfibrozil
The metabolism of Hydromorphone can be decreased when combined with Gemfibrozil.
Glutethimide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Glutethimide.
Glycopyrronium
The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Hydromorphone.
Guanfacine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Guanfacine.
Halazepam
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Halazepam.
Haloperidol
The metabolism of Hydromorphone can be decreased when combined with Haloperidol.
Halothane
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Halothane.
Heroin
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Heroin.
Hexobarbital
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Hexobarbital.
Homatropine
The risk or severity of adverse effects can be increased when Homatropine is combined with Hydromorphone.
Hydrochlorothiazide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Hydrochlorothiazide.
Hydrocodone
Hydromorphone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Hydromorphone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydroflumethiazide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Hydroflumethiazide.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Hydromorphone.
Hyoscyamine
The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Hydromorphone.
Hypoxis hemerocallidea root extract
The serum concentration of Hydromorphone can be decreased when it is combined with St. John's Wort.
Idelalisib
The metabolism of Hydromorphone can be decreased when combined with Idelalisib.
Iloperidone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Iloperidone.
Imatinib
The metabolism of Hydromorphone can be decreased when combined with Imatinib.
Imipramine
The metabolism of Hydromorphone can be decreased when combined with Imipramine.
Indapamide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Indapamide.
Indinavir
The metabolism of Hydromorphone can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Hydromorphone can be decreased when combined with Indinavir.
Ipratropium Bromide
The risk or severity of adverse effects can be increased when Ipratropium bromide is combined with Hydromorphone.
Ipratropium Bromide Anhydrous
The risk or severity of adverse effects can be increased when Ipratropium bromide is combined with Hydromorphone.
Iproniazid
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Iproniazid.
Irbesartan
The metabolism of Hydromorphone can be decreased when combined with Irbesartan.
Isavuconazole
The serum concentration of Hydromorphone can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Hydromorphone can be decreased when combined with Isavuconazonium.
Isocarboxazid
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Isocarboxazid.
Isoflurane
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Isoflurane.
Isoniazid
The metabolism of Hydromorphone can be decreased when combined with Isoniazid.
Isosorbide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Isosorbide.
Isradipine
The metabolism of Hydromorphone can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Hydromorphone can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Hydromorphone can be increased when it is combined with Ivacaftor.
Ketamine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Ketamine.
Ketazolam
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Ketazolam.
Ketoconazole
The metabolism of Hydromorphone can be decreased when combined with Ketoconazole.
Lamotrigine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Lamotrigine.
Leflunomide
The metabolism of Hydromorphone can be decreased when combined with Leflunomide.
Levetiracetam
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Levetiracetam.
Levobupivacaine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Levobupivacaine.
Levocabastine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Levocabastine.
Levocetirizine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Levocetirizine.
Levodopa
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Levodopa.
Levomethadyl
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Levomethadyl Acetate.
Levomilnacipran
Hydromorphone may increase the serotonergic activities of Levomilnacipran.
Levorphanol
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Levorphanol.
Lidocaine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Lidocaine.
Lisdexamfetamine
Lisdexamfetamine may increase the analgesic activities of Hydromorphone.
Lisdexamfetamine Dimesylate
Lisdexamfetamine may increase the analgesic activities of Hydromorphone.
Lithium
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Lithium.
Lithium Cation
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Lithium.
Lopinavir
The metabolism of Hydromorphone can be decreased when combined with Lopinavir.
Loratadine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Loratadine.
Lorazepam
The risk or severity of adverse effects can be increased when Lorazepam is combined with Hydromorphone.
Lorcaserin
The metabolism of Hydromorphone can be decreased when combined with Lorcaserin.
Lormetazepam
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Lormetazepam.
Losartan
The metabolism of Hydromorphone can be decreased when combined with Losartan.
Lovastatin
The metabolism of Hydromorphone can be decreased when combined with Lovastatin.
Loxapine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Loxapine.
Luliconazole
The serum concentration of Hydromorphone can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Hydromorphone can be decreased when it is combined with Lumacaftor.
Lumefantrine
The metabolism of Hydromorphone can be decreased when combined with Lumefantrine.
Lurasidone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Lurasidone.
Magnesium Sulfate
The therapeutic efficacy of Hydromorphone can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Hydromorphone can be increased when used in combination with Magnesium sulfate.
Manidipine
The metabolism of Hydromorphone can be decreased when combined with Manidipine.
Mannitol
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Mannitol.
Maprotiline
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Maprotiline.
Mecamylamine
The risk or severity of adverse effects can be increased when Mecamylamine is combined with Hydromorphone.
Meclizine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Meclizine.
Melatonin
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Melatonin.
Meperidine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Pethidine.
Mephentermine
Mephentermine may increase the analgesic activities of Hydromorphone.
Mephobarbital
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Methylphenobarbital.
Mepivacaine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Mepivacaine.
Meprobamate
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Meprobamate.
Mersalyl
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Mersalyl.
Mesoridazine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Mesoridazine.
Metaxalone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Metaxalone.
Methadone
The metabolism of Hydromorphone can be decreased when combined with Methadone.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Methadyl Acetate.
Methamphetamine
Methamphetamine may increase the analgesic activities of Hydromorphone.
Methantheline
The risk or severity of adverse effects can be increased when Methantheline is combined with Hydromorphone.
Methapyrilene
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Methapyrilene.
Methaqualone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Methaqualone.
Methazolamide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Methazolamide.
Methixene
The risk or severity of adverse effects can be increased when Metixene is combined with Hydromorphone.
Methocarbamol
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Methocarbamol.
Methohexital
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Methohexital.
Methotrimeprazine
Hydromorphone may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Methoxyflurane.
Methscopolamine Bromide
The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with Hydromorphone.
Methsuximide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Methsuximide.
Methyclothiazide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Methyclothiazide.
Methylene blue
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Methylene blue.
Metolazone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Metolazone.
Metoprolol
The metabolism of Hydromorphone can be decreased when combined with Metoprolol.
Metylperon
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Melperone.
Metyrosine
Hydromorphone may increase the sedative activities of Metyrosine.
Midazolam
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Midazolam.
Midostaurin
The metabolism of Hydromorphone can be decreased when combined with Midostaurin.
Mifepristone
The serum concentration of Hydromorphone can be increased when it is combined with Mifepristone.
Milnacipran
Hydromorphone may increase the serotonergic activities of Milnacipran.
Minaprine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Minaprine.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Hydromorphone.
Mirabegron
The metabolism of Hydromorphone can be decreased when combined with Mirabegron.
Mirtazapine
Hydromorphone may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Mitotane
The serum concentration of Hydromorphone can be decreased when it is combined with Mitotane.
Moclobemide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Moclobemide.
Molindone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Molindone.
Moricizine
Moricizine may increase the hypotensive activities of Hydromorphone.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Hydromorphone.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Hydromorphone.
Nalbuphine
Nalbuphine may decrease the analgesic activities of Hydromorphone.
Naltrexone
The therapeutic efficacy of Hydromorphone can be decreased when used in combination with Naltrexone.
Nefazodone
The metabolism of Hydromorphone can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Hydromorphone can be decreased when combined with Nelfinavir.
Netupitant
The serum concentration of Hydromorphone can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Hydromorphone can be increased when combined with Nevirapine.
Nialamide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Nialamide.
Nicardipine
The metabolism of Hydromorphone can be decreased when combined with Nicardipine.
Nilotinib
The metabolism of Hydromorphone can be decreased when combined with Nilotinib.
Nitrazepam
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Nitrazepam.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Nitrous oxide.
Norflurane
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Norflurane.
Normethadone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Normethadone.
Nortriptyline
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Nortriptyline.
Octotropine Methylbromide
The risk or severity of adverse effects can be increased when Anisotropine Methylbromide is combined with Hydromorphone.
Octylonium
The risk or severity of adverse effects can be increased when Otilonium is combined with Hydromorphone.
Olanzapine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Olanzapine.
Olaparib
The metabolism of Hydromorphone can be decreased when combined with Olaparib.
Olopatadine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Olopatadine.
Omeprazole
The metabolism of Hydromorphone can be decreased when combined with Omeprazole.
Ondansetron
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Ondansetron.
Opium
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Opium.
Orphenadrine
Hydromorphone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Osimertinib
The serum concentration of Hydromorphone can be increased when it is combined with Osimertinib.
Oxazepam
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Oxazepam.
Oxitropium
The risk or severity of adverse effects can be increased when Oxitropium is combined with Hydromorphone.
Oxprenolol
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Oxprenolol.
Oxybutynin
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Hydromorphone.
Oxycodone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Oxycodone.
Oxymorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Oxymorphone.
Oxyphenonium
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Hydromorphone.
p-Hydroxyamphetamine
Hydroxyamphetamine may increase the analgesic activities of Hydromorphone.
Palbociclib
The serum concentration of Hydromorphone can be increased when it is combined with Palbociclib.
Paliperidone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Paliperidone.
Pamabrom
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Pamabrom.
Pancuronium
The risk or severity of adverse effects can be increased when Pancuronium is combined with Hydromorphone.
Pancuronium Bromide
The risk or severity of adverse effects can be increased when Pancuronium is combined with Hydromorphone.
Panobinostat
The serum concentration of Hydromorphone can be increased when it is combined with Panobinostat.
Paraldehyde
Hydromorphone may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Hydromorphone.
Pargyline
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Pargyline.
Paroxetine
The metabolism of Hydromorphone can be decreased when combined with Paroxetine.
Peginterferon Alfa-2b
The serum concentration of Hydromorphone can be decreased when it is combined with Peginterferon alfa-2b.
Pegvisomant
The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Hydromorphone.
Pentazocine
Pentazocine may decrease the analgesic activities of Hydromorphone.
Pentobarbital
The metabolism of Hydromorphone can be increased when combined with Pentobarbital.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Hydromorphone.
Perazine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Perazine.
Periciazine
Propericiazine may increase the hypotensive activities of Hydromorphone.
Perphenazine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Perphenazine.
Phenelzine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Phenelzine.
Phenobarbital
The metabolism of Hydromorphone can be increased when combined with Phenobarbital.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Phenoxyethanol.
Phentermine
Phentermine may increase the analgesic activities of Hydromorphone.
PHENTERMINE RESIN
Phentermine may increase the analgesic activities of Hydromorphone.
Phenytoin
The metabolism of Hydromorphone can be increased when combined with Phenytoin.
Pimozide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Pimozide.
Pipamperone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Pipamperone.
Pipecuronium
The risk or severity of adverse effects can be increased when Pipecuronium is combined with Hydromorphone.
Pipothiazine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Pipotiazine.
Pirenzepine
The risk or severity of adverse effects can be increased when Pirenzepine is combined with Hydromorphone.
Piretanide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Piretanide.
Pirinitramide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Piritramide.
Pizotyline
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Pizotifen.
Polythiazide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Polythiazide.
Pomalidomide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Pomalidomide.
Posaconazole
The metabolism of Hydromorphone can be decreased when combined with Posaconazole.
Potassium
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Potassium.
Potassium Citrate
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Potassium Citrate.
Pramipexole
Hydromorphone may increase the sedative activities of Pramipexole.
Pramoxine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Pramocaine.
Prazepam
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Prazepam.
Pregabalin
The therapeutic efficacy of Hydromorphone can be increased when used in combination with Pregabalin.
Prilocaine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Prilocaine.
Primidone
The metabolism of Hydromorphone can be increased when combined with Primidone.
Procaine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Procaine.
Procarbazine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Procarbazine.
Prochlorperazine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Prochlorperazine.
Procyclidine
The risk or severity of adverse effects can be increased when Procyclidine is combined with Hydromorphone.
Profenamine
The risk or severity of adverse effects can be increased when Ethopropazine is combined with Hydromorphone.
Promazine
The metabolism of Hydromorphone can be decreased when combined with Promazine.
Promethazine
Promethazine may increase the hypotensive activities of Hydromorphone.
Propantheline
The risk or severity of adverse effects can be increased when Propantheline is combined with Hydromorphone.
Propantheline Bromide
The risk or severity of adverse effects can be increased when Propantheline is combined with Hydromorphone.
Proparacaine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Proparacaine.
Propiverine
The risk or severity of adverse effects can be increased when Propiverine is combined with Hydromorphone.
Propofol
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Propofol.
Propoxyphene
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Dextropropoxyphene.
Protriptyline
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Protriptyline.
Pseudoephedrine
Pseudoephedrine may increase the analgesic activities of Hydromorphone.
Pyrimethamine
The metabolism of Hydromorphone can be decreased when combined with Pyrimethamine.
Quazepam
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Quazepam.
Quetiapine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Quetiapine.
Quinethazone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Quinethazone.
Quinidine
The metabolism of Hydromorphone can be decreased when combined with Quinidine.
Quinine
The metabolism of Hydromorphone can be decreased when combined with Quinine.
Ramelteon
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Ramelteon.
Ranolazine
The metabolism of Hydromorphone can be decreased when combined with Ranolazine.
Rasagiline
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Rasagiline.
Remifentanil
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Remifentanil.
Remoxipride
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Remoxipride.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Hydromorphone.
Rifabutin
The metabolism of Hydromorphone can be increased when combined with Rifabutin.
Rifampin
The metabolism of Hydromorphone can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Hydromorphone can be increased when combined with Rifapentine.
Rilpivirine
The serum concentration of Hydromorphone can be decreased when it is combined with Rilpivirine.
Risperidone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Risperidone.
Ritonavir
The metabolism of Hydromorphone can be decreased when combined with Ritonavir.
Rolapitant
The metabolism of Hydromorphone can be decreased when combined with Rolapitant.
Ropinirole
Hydromorphone may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Ropivacaine.
Rotigotine
Hydromorphone may increase the sedative activities of Rotigotine.
Rucaparib
The metabolism of Hydromorphone can be decreased when combined with Rucaparib.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Hydromorphone.
Saquinavir
The metabolism of Hydromorphone can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Hydromorphone can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Hydromorphone can be decreased when used in combination with Sarilumab.
Scopolamine
The risk or severity of adverse effects can be increased when Scopolamine is combined with Hydromorphone.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Scopolamine is combined with Hydromorphone.
Secobarbital
The metabolism of Hydromorphone can be increased when combined with Secobarbital.
Selegiline
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Selegiline.
Sertindole
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Sertindole.
Sertraline
The metabolism of Hydromorphone can be decreased when combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Sevoflurane.
Sildenafil
The metabolism of Hydromorphone can be decreased when combined with Sildenafil.
Siltuximab
The serum concentration of Hydromorphone can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Hydromorphone can be increased when it is combined with Simeprevir.
Sodium Oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Hydromorphone.
Solifenacin
The risk or severity of adverse effects can be increased when Solifenacin is combined with Hydromorphone.
Sorafenib
The metabolism of Hydromorphone can be decreased when combined with Sorafenib.
Spironolactone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Spironolactone.
ST. JOHN'S WORT EXTRACT
The serum concentration of Hydromorphone can be decreased when it is combined with St. John's Wort.
Succinylcholine
Succinylcholine may increase the bradycardic activities of Hydromorphone.
Sufentanil
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Sufentanil.
Sulfadiazine
The metabolism of Hydromorphone can be decreased when combined with Sulfadiazine.
Sulfamethoxazole
The metabolism of Hydromorphone can be decreased when combined with Sulfamethoxazole.
Sulfisoxazole
The metabolism of Hydromorphone can be decreased when combined with Sulfisoxazole.
Sulpiride
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Sulpiride.
Suvorexant
Hydromorphone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Hydromorphone.
Tasimelteon
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Tasimelteon.
Telaprevir
The metabolism of Hydromorphone can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Hydromorphone can be decreased when combined with Telithromycin.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Hydromorphone.
Terbinafine
The metabolism of Hydromorphone can be decreased when combined with Terbinafine.
Tetrabenazine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Tetrabenazine.
Tetracaine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Tetracaine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Tetracaine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Hydromorphone.
Thalidomide
Hydromorphone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Theobromine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Theobromine.
Thiamylal
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Thiamylal.
Thiethylperazine
Thiethylperazine may increase the hypotensive activities of Hydromorphone.
Thiopental
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Thiopental.
Thiopental Sodium
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Thiopental.
Thioproperazine
Thioproperazine may increase the hypotensive activities of Hydromorphone.
Thioridazine
The metabolism of Hydromorphone can be decreased when combined with Thioridazine.
Thiothixene
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Thiothixene.
Tiagabine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Tiagabine.
Tiapride
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Tiapride.
Ticagrelor
The metabolism of Hydromorphone can be decreased when combined with Ticagrelor.
Ticlopidine
The metabolism of Hydromorphone can be decreased when combined with Ticlopidine.
Tiotropium
The risk or severity of adverse effects can be increased when Tiotropium is combined with Hydromorphone.
Tipranavir
The metabolism of Hydromorphone can be decreased when combined with Tipranavir.
Tizanidine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Tizanidine.
Tocilizumab
The serum concentration of Hydromorphone can be decreased when it is combined with Tocilizumab.
Tolbutamide
The metabolism of Hydromorphone can be decreased when combined with Tolbutamide.
Tolcapone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Tolcapone.
Toloxatone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Toloxatone.
Tolterodine
The risk or severity of adverse effects can be increased when Tolterodine is combined with Hydromorphone.
Tolvaptan
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Tolvaptan.
Topiramate
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Topiramate.
Torsemide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Torasemide.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Hydromorphone.
Tranylcypromine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Tranylcypromine.
Trazodone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Trazodone.
Triamterene
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Triamterene.
Triazolam
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Triazolam.
Triazulenone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Loprazolam.
Trichlormethiazide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Trichlormethiazide.
Trifluoperazine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Trifluoperazine.
Triflupromazine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Triflupromazine.
Trihexyphenidyl
The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Hydromorphone.
Trihexyphenidyl Hydrochloride
The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Hydromorphone.
Trimeprazine
Alimemazine may increase the hypotensive activities of Hydromorphone.
Trimethaphan
The risk or severity of adverse effects can be increased when Trimethaphan is combined with Hydromorphone.
Trimethoprim
The metabolism of Hydromorphone can be decreased when combined with Trimethoprim.
Trimipramine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Trimipramine.
Triprolidine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Triprolidine.
Tropicamide
The risk or severity of adverse effects can be increased when Tropicamide is combined with Hydromorphone.
Trospium
The risk or severity of adverse effects can be increased when Trospium is combined with Hydromorphone.
Tubocurarine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Hydromorphone.
Umeclidinium
The risk or severity of adverse effects can be increased when Umeclidinium is combined with Hydromorphone.
Urethane
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Ethyl carbamate.
Valproate
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Valproic Acid.
Valproic Acid
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Valproic Acid.
Valsartan
The metabolism of Hydromorphone can be decreased when combined with Valsartan.
Vecuronium
The risk or severity of adverse effects can be increased when Vecuronium is combined with Hydromorphone.
Vemurafenib
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Hydromorphone.
Venlafaxine
The metabolism of Hydromorphone can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Hydromorphone can be decreased when combined with Verapamil.
Vigabatrin
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Vigabatrin.
Voriconazole
The metabolism of Hydromorphone can be decreased when combined with Voriconazole.
Vortioxetine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Vortioxetine.
Zafirlukast
The metabolism of Hydromorphone can be decreased when combined with Zafirlukast.
Zaleplon
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Zaleplon.
Ziconotide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Ziconotide.
Ziprasidone
The metabolism of Hydromorphone can be decreased when combined with Ziprasidone.
Zolpidem
Hydromorphone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Zonisamide.
Zopiclone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Zopiclone.
Zotepine
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Zotepine.
Zuclopenthixol
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Zuclopenthixol.